Bifurcation Squared: Compass Lobbies for Narrow Rescheduling in Colorado, Virginia; Pushes Back on State Policy Reforms Post published:January 23, 2025 Post category:Analysis/News
Psychedelics in 2024: From Hype to Hard Realities Post published:January 21, 2025 Post category:2024 Year in Review/Analysis/News
PsychedeliCare Launches First European Citizens’ Initiative Demanding Political Action on Psychedelic-Assisted Therapies Post published:January 14, 2025 Post category:Analysis/News
Billionaire Investor Antonio Gracias Plots $100M Lykos Takeover with Doblin’s Backing Post published:January 10, 2025 Post category:Analysis/News/Pα+
From Fringe to Focus: APA’s American Journal of Psychiatry Publishes Special Issue on Psychedelics Post published:January 7, 2025 Post category:Analysis/News/Pα+
Psychedelic Alpha’s Top 11 Stories from 2024 Post published:December 26, 2024 Post category:2024 Year in Review/Analysis/News
SCOOP: PSFC’s $130M Roadmap to Shape the Future of Psychedelic Philanthropy Post published:December 20, 2024 Post category:Analysis/News/Pα+
Psychedelic Drug Development Under Trump 2.0: Health Nominees Signal Uncertain Future Post published:November 30, 2024 Post category:Analysis/News/Pα+
Q3’24 Survey: What are Psychedelics Investors Concerned About? Post published:November 27, 2024 Post category:Analysis/News/Pα+
Interviews: Meet the Team Who Challenged the DEA on DOI and DOC Post published:November 26, 2024 Post category:Analysis/News